When can weekly anti‐obesity peptides be used for monthly administration?
Diabetes, Obesity and Metabolism · 2025-03 · 27 (3) · 1628-1629
DOI: 10.1111/dom.16134 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 20.12.2024. Verfasst von Daniel V Santi. Beteiligte Einrichtung: ProLynx, San Francisco, California, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.16134. Data is available to all.
Autor:innen und Institutionen
- ProLynx, San Francisco, California, USA.
- Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.
ORCID-Profile: Daniel V Santi
Zitieren
APA
Santi, D. V. (2025). When can weekly anti‐obesity peptides be used for monthly administration?. Diabetes, Obesity and Metabolism, 27(3), 1628-1629. https://doi.org/10.1111/dom.16134
Vancouver
Santi DV. When can weekly anti‐obesity peptides be used for monthly administration?. Diabetes, Obesity and Metabolism. 2025;27(3):1628-1629. doi:10.1111/dom.16134
BibTeX
@article{Santi2025,
author = {Santi, Daniel V},
title = {When can weekly anti‐obesity peptides be used for monthly administration?},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {3},
pages = {1628--1629},
doi = {10.1111/dom.16134}
}
EUVIMED